Document:

WWW.EXFILE.COM, INC. -- 888-775-4789 -- ZAP -- EXHIBIT 10.1 TO FORM 8K

    
      	
              EXHIBIT
      10.1   

            	
                                                                   ZAP(Hangzhou)
      Electric Vehicle

              Co.,
      Ltd  Joint Venture Contract

            

    

     
 

     

     

     

    

    Chinese-Foreign Jointly
Funded

    Zap
(Hangzhou) Electric Vehicle Co., Ltd

    

      Joint
Venture Contract

     

    Chapter
1   General

    .

    ZAP
(hereafter referred to as Party A), BETTER WORLD LIMITED (hereafter referred to
as Party B) and Holley Group Co., Ltd (hereafter referred to as Party C) hereby
agree to conclude this joint venture contract and jointly fund a Chinese-foreign
joint venture in Hangzhou, Zhejiang Province, the People’s Republic of
China, according to the Law of the People’s Republic of China on Chinese-Foreign
Joint Ventures and other Chinese regulations, in line with the principles of
equality and mutual benefit, and through friendly consultation.

    

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    Chapter2   Joint
Venture parties

    

    Article
1: JOINT VENTURE parties for this contract:

     

    Party A:
ZAP Registered in: USA

    Legal
address: 501 Fourth Street Santa Rosa, CA 95401

    Legal
representative: Steven Mark Schneider   Nationality:
USA

    Telephone:
001-7075258658

     

    Party B:
BETTER WORLD LIMITED     Registered in: Hong
Kong

    Legal
Address: Apartment 10A Ede Road Kowloon Tong KL

    Legal
representative: Lu
Meiheng               Nationality:
USA

    Telephone:
85225220551

     

    Party C:
Holley Group Co.,
Ltd             Registered
in: China

    Legal
address: 181 Wuchang Avenue, Yuhang District, Hangzhou

    Legal
representative: Wang Licheng

    Telephone:
0571-88900688

     

     

    Chapter
3   Establish a joint venture

    

    Article
2: according to the Law of the People’s Republic of China on Foreign-Funded
Enterprises and other related Chinese regulations, Party A, B and C agree to
establish the Chinese-foreign jointly funded Zap (Hangzhou) Electric Vehicle Co.,
Ltd, (hereafter referred to as “joint venture”) in
China.

     

    Article
3: the name of joint venture:
Zap (Hangzhou) Electric Vehicle Co., Ltd; legal address of joint venture:
Building 1, 181 Wuchang Avenue, Yuhang District, Hangzhou; zip code:
310011.

     

    Article
4: all the activities of joint venture must be in accordance with the laws, acts
and related regulations of the People’s Republic of China.

     

        Article
5: the organizational form of joint venture is Limited Liability Company. .
Party A, B and C shall assume the debt of joint venture according to
their own amount of contribution to capital. 
The parties shall also share the profits, risks and loss according to
their own amount of contribution to registered capital.

     

    

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    Chapter
4    Business purpose, scope and scale

    

    Article
6: the purpose of Party A, B and C to establish a joint venture: being desirous
of enhancing economic cooperation and technical exchange, through advanced and
applicable technology and rational operating management methods, the three
parties will improve economic performance and gain satisfactory economic
interests..

     

    Article
7: business scope of joint venture: research & development, production and
sale of battery system, driving system, electronic control system for electric
vehicle; research & development of electric vehicle and consultation on
electric vehicle technology..

     

    Article
8: business scale of joint venture: annual revenue of 10 Million US
dollars..

     

    

    

    Chapter
5    Total amount of investment and registered
capital

    

    Article
9: the total amount of investment for joint venture is 3 Million US dollars.
.
Registered capital of joint venture is 3 Million US dollars..

     

    Article
10: the total amount of investment by Party A, B and C is 3 Million US dollars
taken as the registered capital of joint venture. .
Proportions: 1.125 Million US dollars from Party A accounts for 37.5%;
1.125 Million US dollars from Party B accounts for 37.5%; and 750 Thousand US
dollars from Party C accounts for 25 %..

     

                
Article 11: Party A, B and C will contribute their investment in the following
way:.

     

    Party A:
1.125 Million US dollars, at current exchange rate of US dollars.

     

    Party B:
1.125 Million US dollars, at current exchange rate of US dollars.

     

    Party C:
750 Thousand US dollars, Equivalent in RMB .
(US dollars converted into RMB at the exchange rate on the day of
registration)..

     

    Article
12: the registered capital of joint venture will be paid up by Party A, B and C
according to their ratio of contribution within two months from the issue date
of joint venture business license..

     

    Article
13: any one of Party A, B and C shall not wholly or partly transfer his amount
of investment to any third party without the prior permission of the other two
parties and without the approval from original approving authority. The other
two parties have the first right of refusal to purchase the investment amount,
wholly partially transferred by the third party when any one party wholly or
partly transfers his amount of investment.

    

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    Chapter
6   Responsibility of JV parties

     

    Article
14: Party A, B and C shall be responsible for the following
business:

     

    Responsibility
of Party A and B:.

     

    1.
Contribute investment according to the provisions of Chapter V;.

     

    2. Make
transactions related to purchase of mechanical equipment and material etc.
outside China for the joint venture;.

     

    3.
Provide technical staff for equipment installation and testing, production and
quality inspection;.

     

    4.
Provide technical training to joint venture staff; .

     

    5.
Conduct other business under the entrustment of joint venture.

     

    Responsibility
of Party C

     

    1. Apply
to relevant authorities of China for establishment approval, registration and
business license of joint venture, of which, the expenses shall be assumed by
joint venture;.

     

    2.
Contribute investment according to the provisions of Chapter 5;.

     

    3. Assist
the joint venture to apply to authorities in charge of land for land-use
right;.

     

    4. Assist
the joint venture to complete import entry procedures for purchase of equipment
and material etc. outside of China and the transportation within Chinese
territory;.

     

    5. Assist
the joint venture to purchase or rent equipment, raw material, office supplies,
vehicles and communication facilities etc. within Chinese territory;.

     

    6. Assist
the joint venture to complete the basic facilities related to water, electricity
and transportation etc..

     

    7. Assist
the joint venture to recruit local Chinese operating management personnel,
technologists, workers and other required personnel;.

     

    8. Assist
foreign working personnel to apply for entry visa, work permit and handle their
travel procedures;.

     

    9.
Conduct other business under the entrustment of joint venture.

       

    Chapter
7      Sales

     

    Article
15: selling of products of joint venture in the market within Chinese
territory.

     

    Article
16: for the purpose of selling products and providing after-sale service in and
outside of China, the joint venture can establish branches in and outside of
China with the approval of the Chinese authorities..

     

    Article
17: the trademark used for products of joint venture is determined by the board
of directors, and relevant procedures shall be handled according to the
Trademark Law of the People’s Republic of China.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    Chapter
8   Company organization and its establishment method, authority
and rules of procedure

    

    Article
18: establish the board of directors of joint venture. 
Board of directors is the highest authority of joint venture. .
The board of directors makes decisions on all significant events of the
joint venture and has the following authority:

     

    1.
Determination and approval of important reports presented by general
manager;

     

    2. Define
the joint venture’s business plans and investment programs;

     

    3.
Determine the annual financial budget and final account schemes of joint
venture;

     

    4. Make
profit distribution and loss recovery plans of joint venture;

     

    5. Make
the joint venture’s plans for the increase or reduction of registered capital
and for the issue of debenture;

     

    6. Make
plans for stock share transfer, consolidation, separation, change of company
structure, and dissolution of the company;

     

    7.
Determine the internal structure of administrative organization of the
company;

     

    8. Decide
the appointment or dismissal of general manager, deputy general manager, chief
engineer and chief financial officer and their remuneration, and decide the
appointment or dismissal of deputy general manager, chief engineer, chief
financial officer and their remuneration according to the name list submitted by
general manager;

     

    9.
Establish the fundamental management system of company;.

     

    10.
Approve the transaction related to share holders, the enterprises actually
controlled by share holders or the affiliated enterprises of share
holders;

     

    11.
Decide the matters related to the provision of security to foreign parties and
the lending of capital by the company;

     

    12. Make
decisions on other significant events that shall be decided by the board of
directors.

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

    Article
19: the board of directors is composed of 5 directors, of which, 2 are from
Party A, 2 are from Party B and 1 is from Party C. The term of the chairman and
directors is three years, and can be re-appointed..

     

    Article
20: the first board chairman shall be appointed by Party B; after the expiration
of the term of three years, the board chairman shall be appointed by Party A;
the chairman rotates every three years..

     

    Article
21: Party A, Party B and Party C shall issue a written notice to Board of
Directors in case of appointing and replacing any director candidate. In case of
replacing Chairman or Vice Chairman, a written notice shall be issued to Board
of Directors as well as other parties and shall be submitted to approving
authority for approval.

     

    Article
22: Regular meetings of the Board shall be convened at least twice every year by
the Chairman in January and July. In case meeting of the Board is proposed by
Chairman or one third of directors or requested by General Manager due to
operation and management requiring discussion and resolution of the Board,
Chairman must convene interim meeting of the Board within 45 days after
receiving the proposal or request.

     

    Article
23: In principle, meetings of the Board shall be convened at the locality of the
Company. Otherwise, approval of more than three fourth of directors shall be
obtained.

     

    Article
24: Board meetings shall be convened and presided over by Chairman. Chairman
shall entrust other directors to convene and preside over the Board meeting in
case he fails to convene the meeting. If Chairman fails to convene the meeting
and entrust other directors to convene the meeting, a new Chairman shall be
elected by more than one third of directors to convene meeting of the
Board.

     

    Article
25: Chairman shall issue written notices to all directors 30 days before meeting
of the Board, with content of meeting, time and venue included.

     

    Article
26: In case of failing to attend the meeting, any director can authorize
representative to attend the meeting. If any director fails to attend the
meeting and fails to authorize any representative to attend the meeting, the
director is deemed to approve all proposals on the meeting.

     

    Article
27: Meeting of the Board shall be effective only when a quorum of two thirds of
directors attend the meeting and at least one director from Party A, Party B and
Party C respectively attend the meeting. In case the number of directors fails
to reach the quorum, decisions made on the meeting shall be null and
void.

     

    Article
28: Detail written records shall be made on each meeting of the Board and shall
be signed by all directors attending the meeting. In case representative is
entrusted to attend the meeting, the representative shall sign the record which
is written in Chinese and filed by the Company.

     

    Article
29: Decision on issues hereunder shall be made only after all directors of the
Company have reached unanimous agreement through negotiation:

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

     (1)
Revision of By-law of the
Joint Venture;

     

     (2)
Termination and dissolution of the Joint Venture and extension of joint venture
period;

     

     (3)
Addition and transfer of registered capital of the Joint Venture;

     

     (4)
Merger of the Joint Venture and other economic organizations;

     

     (5)
Affiliated transaction (including dealings of raw materials and different
charges) between the Joint Venture and shareholders, other enterprises
controlled by shareholders or affiliated enterprises of
shareholders;

     

     (6)
Investment by the Joint Venture;

     

     (7)
The decision to appoint or dismiss General Manager, Deputy General Manager,
Chief Engineer and CFO, and issues related with their remuneration; General
Manager’s proposal to appoint or dismiss Deputy General Manager, Chief Engineer
and CFO, and issues related with their remuneration; General Manager’s proposal
for salary and incentive system, annual salary system and the year-end staff
rewards solution;

     

     (8)
Decision on external guarantee (excluding guarantee for loans of the Joint
Venture) by the Joint Venture;

     

     (9)
Decision on capital loan of the Joint Venture to outside (fund of disbursement
for staff is executed as per management system of the Company).

     

    Article
30: Decision on other issues shall be effective after obtaining approval of more
than two thirds of directors on the meeting.

     

    Article
31: Board of Supervisors is not established in the Joint Venture. One supervisor
shall be appointed by Party A.

     

    Article
32: Supervisor shall have three years of tenure of office and can serve for
another term of office through election. Chairman, Manager and financial
administrator shall not be appointed as Supervisor.

     

    Article
33: Supervisor shall be in the charge of Board of Directors and shall execute
rights hereunder as specified by Law of Company,

     

     (1)
Audit on finance of the Joint Venture;

     

     (2)
Supervise directors and management staff of the Joint Venture and propose to
dismiss any director or management personnel who has breach laws, administrative
regulations, By-law of joint venture or decisions made on
the meeting of Shareholders;

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

     (3)
Require directors or management staff to make rectification when any act thereof
causes harm to company interests;

     

     (4)
Propose to convene interim meeting of the Board of Directors. Convene and
preside over meeting of the Board if the Board of Directors fails to perform its
duty to convene and preside over the meeting as specified by the
Law;

     

     (5)
Submit proposal to the meeting of shareholders;

     

     (6)
Take proceedings against any director or management staff as per Article 152 of
the Law;

     

     (7)
Other rights as specified By-law of the joint venture.

     

    Article
34: Supervisor can be present at meeting of the Board of Directors and raise
questions or suggestions on proposals on the meeting.

     

    Article
35: Executive management team of the Joint Venture shall include Manufacturing
Department, Technical Department, Financial Department, Sales Department and
General Administration Department.

     

    Article
36: The Joint Venture shall have a General Manager appointed by the Board of
Directors.

     

    Article
37: General Manager shall report to the Board of Directors to execute decisions
thereof and manage daily manufacturing, technical, operation and
management.

     

    Article
38: General Manager shall have three years of term of office and can continue in
office if re-appointed by the Board of Directors. Deputy General Manager, Chief
Engineer and CFO shall be nominated by General Manager and appointed or
dismissed by the Board of Directors.

     

    Article
39: Chairman or any director can also serve as General Manager or other senior
positions after appointed by the Board of Directors.

     

    Article
40: General Manager shall not take office as general manager of other economic
organizations and shall not take part in commercial competition conducted by
other economic organizations against the Joint Venture.

     

    Article
41: General Manager
Assistant as well as director or above as set in the Joint Venture shall be
nominated by General Manager and appointed or dismissed by the Board of
Directors.

     

    Article
42: Senior management staff such as engineers and accountants shall be under the
Management of General Manager.

     

    Article
43: When General
Manager and other senior management personnel resign, they shall submit prior
written report to the Board of Directors before resignation.

     

    The
above-mentioned personnel shall be dismissed after resolution is made by the
Board of Directors in case of graft, serious dereliction of duty or serious
breaching of management system of the Joint Venture. 

    

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

    Chapter
9   Legal Representative of the Company

     

    Article 44: The Legal
Representative of the Company is held by the Chairman

    

    Chapter
10   Materials, Equipment Purchases and Land
Use

     

    Article 45: Materials,
component parts, transportation vehicles and office supplies needed by the Joint Venture
shall be purchased in China with the same quality.

     

    Article
46: When the Joint Venture entrusts Party A with the purchase of equipments in
foreign markets, Party B shall be invited to involve in the
purchase.

     

       Article
47: The Joint Venture shall be responsible for entering into the land use
contract with respect to the area and scope of the land needed by the Joint
Venture by the approval of the land authority.

    

    Chapter 11 Labor
Management

    

        Article
48: the Joint Venture and the trade union of the Joint Venture shall enter into,
collectively or individually, labor contracts between employees of the Joint
Venture with respect to issues such as their employments, dismissals, wages,
labor insurances, welfares and incentives according to the “Labor Law of the
People’s Republic of China” and other relevant provisions guided by a program
set up by the Board of Directors. Such labor contracts shall be filed with the
local labor management department after signing.

    

    Chapter
12 Taxation, Finance, Auditing, Foreign Exchange

    

    Article
49: the Joint Venture and its employees should pay all the taxes in accordance
with relevant laws and regulations of China.

     

    Article 50: All the matters concerning
foreign exchange of the Joint Venture shall be executed in accordance with the
“Regulations on the Foreign Exchange System of
the People’s Republic of China”
and the relevant regulations.

     

    Article
51: In accordance with the “Foreign Enterprise Law of the People’s Republic of
China”, the Joint Venture shall extract all sorts of funds, the ratio of which
shall be discussed and determined by the Board of Directors based on business
situation of the Company.

     

    Article
52: the Joint Venture’s fiscal year is from January 1 to December 31 each year.
All accounting vouchers, receipts, reports, books shall be written in
Chinese.

     

    Article
53: the Joint Venture shall engage in the accountants registered in China to
review and audit its finance, and report to the Board of Directors and the
General Manager on the results.

     

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

    If any
party of Party A, B and C think it necessary to individually engage in an
accountant registered in China to carry out the review and auditing, the Joint
Venture will consent to it, however, all the expenses required will be borne by
that party.

     

    Article
54: The General Manager shall organize the preparation of the balance sheet,
profit and loss statement and profit distribution plan for the previous year in
the first three months of each fiscal year, and submit to the Board meeting for
review and approval.

     

    Article
55: If the Joint Venture’s foreign exchange cannot be balanced, Party A, B, C
will distribute the profits in RMB.

    

    Chapter 13  Duration of the Joint
Venture

    

    Article
56: The duration of the Joint Venture is 20 years. The incorporation date of the
Joint Venture is the date on which the Joint Venture’s business license is
issued.

     

    Each of
the parties may propose, by the unanimous passing in the Board meeting, to apply
to the original approval authority for the extension of the duration of the
Joint Venture six months before its expiry.

    

    Chapter
14 Properties Treatment upon Expiry of the Joint Venture

    

    Article
57: If the Joint Venture expires on its duration or early termination, it shall
be liquidated in accordance with the laws and regulations of the People’s
Republic of China. Properties upon liquidation shall be allocated among Party A,
B and C in proportion to their investments.

    

    Chapter
15 Insurance

    

         Article 58: The Joint Venture
shall cover all of its insurances in an insurance institution in the People’s
Republic of China. The insurance cover, insurance value and the insurance period
shall be discussed and determined by the Board meeting of the Joint Venture in
accordance with relevant provisions.

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

    Chapter
16 Amendment, Alteration and Termination of the Contract

    

    Article
59: The amendments of the contract and other appendices shall come into force
only after a written agreement has been reached among Party A, Party B and Party
C and approved by the original Examination and Approval Authority.

     

    Article
60: In case of inability to fulfill the contract as a result of force majeure,
or to continue operation due to heavy losses of the joint venture company in
successive years, the duration of the joint venture and the contract shall be
terminated prior to the time of expiration after being unanimously agreed upon
by the board of directors and approved by the original Examination and Approval
Authority.

     

    Article
61: Should the joint venture company be unable to continue its operation or
achieve its business purpose hereto due to the fact that one of the contracting
parties fails to fulfill the obligations prescribed by the contract and By-law,
or seriously violates the provisions of the contract and By-law, that party
shall be deemed to have unilaterally terminated the contract, for which, the
observant party shall have the right to terminate the contract in accordance
with the provisions of the contract after approval by the original Examination
and Approval Authority, and to claim damages. In case Party A, Party B and Party
C of the joint venture company agree to continue the operation, the party who
fails to fulfill its obligations shall be liable for the economic losses caused
thereby to the joint venture company.

     

     

    Chapter
17 Liability for Breach of Contract

    

    Article
62: Should any Party A, Party B and Party C fail to pay on schedule the
contributions in accordance with the provisions defined in Chapter 5 of this
contract, the party in breach shall be subject to the Law of the PRC on
Chinese-Foreign Equity Joint Ventures, relevant laws and
regulations.

    

    Article
63: Should all or part of the contract and its appendices be unable to be
fulfilled owing to the fault of one party, the party in breach shall bear the
liability therefore. Should it be the fault of the three parties, they shall
bear their respective liabilities according to the actual
situation.

     

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

    

    Chapter18  
Force Majeure

     

    Article
64: Should any of the parties to the contract be prevented from executing the
contract by force majeure, such as earthquake, typhoon, flood, fire, war or
other unforeseen events for which the occurrences and consequences are
unpreventable and unavoidable, the prevented party shall notify the other
parties by telegram without any delay, and within 15 days thereafter provide
detailed information of the events and a valid document for evidence issued by
the relevant public notary organization explaining the reason of its inability
to execute or delay the execution of all or part of the contract. The three
parties shall, through consultations, decide whether to terminate the contract
or to exempt part of the obligations for implementation of the contract or
whether to delay the execution of the contract according to the effects of the
events on the performance of the contract.

     

    Chapter
19  Applicable Law

     

    Article
65: The formation, validity, interpretation, execution and settlement of
disputes in respect of this contract shall be governed by the relevant laws of
the People s Republic of China.

     

     

    Article 66: Any
disputes arising from the execution of, or in connection with, the contract
shall be settled through friendly consultations among the three parties. In case
no settlement can be reached through consultations, the disputes shall be
submitted to the China International Economic and Trade Arbitration Commission
for arbitration in accordance with its rules of procedure. The arbitral award is
final and binding upon all parties.

     

    Article
67: During the arbitration, the contract shall be observed and enforced by all
parties except for the matters in dispute.

     

    Chapter
20   Effectiveness of the Contract and Miscellaneous

     

    Article
68: The contract and its appendices are compiled in Chinese.

     

    Article
69: The ancillary agreements drawn up in accordance with the principles of this
contract are integral parts of this contract, including By-law of the Joint
Venture.

     

    Article
70: The contract and its appendices shall come into force commencing from the
date of approval of the Ministry of Foreign Trade and Economic Cooperation of
the People s Republic of China (or its entrusted examination and approval
authority).

     

    Article
71: Should notices in connection with any party’s rights and obligations be sent
by any Party by telegram or fax, etc., the written letter notices shall be also
required afterwards. The legal addresses of Party A, Party B and Party C listed
in this contract shall be the posting addresses thereof.

     

    
      
        
        

      

      
        12

        
          

        

      

      
        
        

      

    

     

    (This
page contains no text and be only used for signature regarding the Joint Venture
Contract)

    

     

    
      	 	
              Party
      A: ZAP

              Signature
      of Legal representative:

            	
               

              /s/
      Steven M. Schneider

              
                
      

            	 
	 	 	 	 
	 	
              Party
      B: BETTER WORLD LIMITED

              Signature
      of Legal representative:

            	
               

              /s/
      Priscilla Lu   

              
                
      

            	 
	 	 	 	 
	 	
              Party
      C: Holley Group Co., Ltd.

              Signature
      of Legal representative:

            	
               

              /s/ Richard Wong 
      

              
                
      

            	 

    

    

    

    Date of
signature: December 11, 2009

    

    

    
      
        
        

      

      
        13nkemploymntagrmnt.htm

     

    AMENDED AND RESTATED
EMPLOYMENT AGREEMENT

    

    This
AMENDED AND RESTATED EMPLOYMENT AGREEMENT (“Agreement”) is entered into as of
December 14, 2009 (the “Effective Date”) between InVentiv Health, Inc., a
Delaware corporation with its principal place of business at 500 Atrium Drive,
Somerset, NJ 08873, any parent, subsidiary, affiliate, predecessor, or other
related company (collectively the “Company”), and Nat Krishnamurti (the
“Employee”).

    

    W I T N E S S E T H
:

    

    WHEREAS,
the Company desires to continue retaining the services of Employee and the
Employee desires to be employed by the Company, on the terms and subject to the
conditions set forth in this Agreement.

    

    WHEREAS,
the Company and the Employee entered into an Employment Agreement dated April
30, 2008 (the “Employment Agreement”).

    

    WHEREAS,
the Company and the Employee entered into a letter agreement regarding Change in
Control Benefits dated April 30, 2008 (the “Change in Control Letter”), which
Change in Control Letter is no longer in force.

    

    WHEREAS,
this Agreement is intended to amend and restate the Employment Agreement and
supersede the Change in Control Letter.

    

    NOW,
THEREFORE, in consideration of the mutual covenants herein contained, and in
consideration of the continuing employment of Employee by the Company, the
Employment Agreement is hereby amended and restated in its entirety as set forth
herein, the Change in Control Letter is superseded as set forth herein, and the
parties agree as follows:

    

    1. Employment.  The
Company hereby offers to employ the Employee, and the Employee hereby accepts
employment by the Company, in the capacity and upon the terms and conditions
hereinafter set forth.

    

    2. Duties.  The
Employee shall serve as the Company’s Chief Accounting Officer, and shall
perform such duties, functions and responsibilities as are associated with and
incident to that position and as the Company may, from time to time, require of
Employee.  The Employee shall serve the Company faithfully,
conscientiously and to the best of the Employee’s ability and shall promote the
interests and reputation of the Company.  Unless prevented by sickness
or disability, the Employee shall devote all of the Employee’s time, attention,
knowledge, energy and skills, during normal working hours, and at such other
times as the Employee’s duties may require, to the duties of the Employee’s
employment.  The principal place of employment of the Employee shall
be at Employer’s Somerset area office and/or such other location subject to
Section 6(d)(ii) as shall be necessary for the Employee to discharge the
Employee’s duties hereunder.  The Employee acknowledges that in the
course of employment the Employee may be required, from time to time, to travel
on behalf of the Company.

     

        3. Compensation and
Benefits.  As full and complete compensation for the
Employee’s
execution and delivery of this Agreement and performance of any services
hereunder, the Company shall pay, grant or provide the Employee, and the
Employee agrees to accept, the following compensation and benefits:

    

    a. Base
Salary.   The Company shall pay the Employee a base salary
at an annual rate of $235,000.00, less applicable withholding and payable at
such times and in accordance with the Company’s customary payroll practices as
they may be adopted or modified from time to time.  On an annual basis
or at such other times as the Company may determine, the Company may review the
Employee’s performance and determine whether, in its sole discretion, the
Company will increase (but not decrease) the Employee’s base salary. At no time
during the pendency of this Agreement shall the Company, without the written
consent of the Employee, materially decrease the Employee’s base pay. Employee
acknowledges that he shall not be entitled to a merit increase in
2010.

    

    b. Fringe
Benefits.  The Company shall afford the Employee the
opportunity to participate in any health care, dental, disability insurance,
retirement, savings and any other employee benefits plans, policies or
arrangements which the Company maintains for its employees in accordance with
the written terms of such plans, policies or arrangements.  Nothing in
this Agreement shall require the Company to establish, maintain or continue any
benefit plans, policies or arrangements or restrict the right of the Company to
amend, modify or terminate any such benefit plan, policy or
arrangement.  In addition, Employee is covered under the Company's
D&O insurance policy and is indemnified under the Company’s certificate of
incorporation and by-laws for acts and omissions in the performance of his
duties as an officer of the Company to the fullest extent permitted under
Delaware law.

    

    c. Bonus.  The
Employee shall be eligible for a bonus in each calendar year, based on the
Employee’s success in reaching or exceeding performance objectives as determined
by the Compensation Committee of the Company’s Board of Directors (the
“Committee”) as recommended by the Chief Executive Officer or his/her designee,
the amount of such bonus, if any, to be determined in the discretion of the
Company, and subject to the Employee remaining employed by the Company through
the bonus payout date.  The bonus range shall be between 0 - 100% (50%
target) of the Employee’s then current base salary, with the amount of such
bonus, if any, that is awarded remaining subject to the discretion of the
Company.

    

    d. Stock
Option.  It will be recommended to the Committee that the
Employee be granted a stock option with a fair value (based on the Company's
accounting valuation methodology) equal to $125,000 on the date of grant, at an
exercise price per share equal to 100% of the fair market value of the Company’s
common stock on the date of grant (the “Option”).  The Option will
vest over a four (4) year period, subject to the Employee’s continued service
with the Company through the relevant vesting dates.  The Option will
be subject to the terms, definitions and provisions of the Company’s stock plan
(the “Plan”) and the stock option agreement to be entered into by and between
Employee and the Company (the “Option Agreement”), both of which documents are
incorporated herein by reference.

    

    e. Restricted
Stock.  It will be recommended to the Committee that the
Employee be granted a restricted stock award or restricted stock unit award with
a fair value  (based on the Company's accounting valuation
methodology) equal to $125,000 on the date of grant (the “Restricted
Stock”).  The Restricted Stock will vest over a four (4) year period,
subject to the Employee’s continued service with the Company through the
relevant vesting dates.  The Restricted Stock will be subject to the
terms, definitions and provisions of the Plan and the agreement to be entered
into by and between the Employee and the Company (the “Restricted Stock
Agreement”), both of which documents are incorporated herein by
reference.

    

    f. Equity
Awards.  The Employee will be eligible to receive awards of
stock options, restricted stock or other equity awards pursuant to any plans or
arrangements the Company may have in effect from time to time.  The
Committee will determine in its discretion whether the Employee will be granted
any such equity awards and the terms of any such award in accordance with the
terms of any applicable plan or arrangement that may be in effect from time to
time.

    

    g. Expenses.  The
Employee shall be entitled to reimbursement or payment of reasonable business
expenses in accordance with the Company’s policies, as the same may be amended
from time to time in the Company’s sole discretion, following the Employee’s
submission of appropriate receipts, bills and/or expense reports to the Company
in accordance with such policies.

    

    h. Vacations, Holidays or
Temporary Leave:  The Employee shall be entitled to take five
(5) weeks of vacation per year, without loss or diminution of compensation in
accordance with the Company’s policy.  Such vacation shall be taken at
such time or times consistent with the needs of the Company’s
business.  The Employee shall further be entitled to the number of
paid holidays, and leaves for illness or temporary disability in accordance with
the Company’s policies as such policies may be amended from time to time or
terminated in the Company’s sole discretion.  The Company reserves the
right to cancel or change the benefit plans and programs it offers to its
employees at any time.

     

        4. Non-Competition, Confidentiality, Discoveries
and Works.

     

              a. Non-Competition.  During the
period of the Employee's employment
at the Company and for twelve (12) months following the termination, for any
reason, of the Employee’s employment, the Employee agrees not to compete in any
manner, either directly or indirectly, whether for compensation or otherwise,
with the Company, or to assist any other person or entity to compete with the
Company either:

    

    (i) by
producing, developing or marketing, or assisting others to produce, develop or
market, or

    

    (ii) by
accepting employment from or having any other relationship (including, without
limitation, through owning, managing, operating, controlling or consulting) with
any entity which produces, develops or markets, a product, process, or service
which is competitive with those products, processes, or services of the Company,
whether existing or planned for in the future, on which the Employee has worked,
or concerning which the Employee has in any manner acquired knowledge of or had
access to Confidential Information (as defined in Section 4(e)(iii) below),
during the five (5) years preceding termination of the Employee’s employment,
provided, however, that it
shall not be a violation of this Agreement for the Employee to seek and/or
accept employment directly with a fully integrated pharmaceutical or bio-tech
company (i.e. one that discovers, develops, manufactures, and promotes drugs) or
to have beneficial ownership of less than 1% of the outstanding amount of any
class of securities listed on a national securities exchange or quoted on an
inter-dealer quotation system.

    
          b. Non-Solicitation.  During
the period of the Employee’s employment at the Company and for twelve (12)
months following the termination, for any reason, of the Employee’s employment,
the Employee agrees that the Employee will not, either on the Employee’s own
behalf or on behalf of any other person or entity  (other than for the
benefit of the Company), directly or indirectly, (i) solicit any person or
entity that is a customer of the Company, or has been a customer of the Company
during the prior twelve (12) months, to purchase any products or services the
Company provides to the customer, or (ii) interfere with any of the Company’s
business relationships.

     

              c. No-Hire.

     

                 (i) during the period of the Employee's
employment at the Company
and for twelve (12) months following the termination, for any reason, of the
Employee’s employment, the Employee agrees that the Employee will not, either on
the Employee’s own behalf or on behalf of any other person or entity, directly
or indirectly, hire, solicit or encourage to leave the employ of or engagement
by the Company any person who is then an employee or contractor of the Company
or who was an employee or contractor of the Company within six (6) months of the
date of such hiring, soliciting, or encouragement to leave the
Company.

     

                 (ii) during
the period of the Employee’s employment at the Company, and for twelve (12)
months following the termination, for any reason, of the Employee’s employment,
the Employee shall neither seek nor accept employment from any customer,
employee or consultant, which is or has been a customer, employee or consultant
of the Company during the prior twelve (12) months without prior written
approval of the Company.

     

              d. Geographic
Scope.  The foregoing restrictions shall apply in the
“Restricted Area” which means:

    

    (i) the
geographic area in which the Company conducts business or has Covered Customers,
as well as those geographic areas that the Company has a bona fide intention to
engage in the future, or

    

    (ii) any
location, storefront, address or place of business where a Covered Customer is
present and available for solicitation.

     
 

    The
Employee will not circumvent the purpose of any restriction contained in
Sections 4(a), 4(b) or 4(c) by engaging in business outside the Restricted Area
through remote means like telephone, correspondence or computerized
communication.  “Covered Customer” means those customers, entities
and/or persons who did business with the Company and that the Employee either
(x) received Confidential Information about in the course of his/her duties, (y)
had contact with within the last twelve (12) month period of employment by the
Company, or (z) supervised contact with within the last twelve (12) month period
of employment with the Company.

     

             e. Confidentiality.

    

    (i) During
the period of the Employee’s employment at the Company and for all time
following the termination, for any reason, of the Employee’s employment, the
Employee shall hold all Confidential Information of the Company in a fiduciary
capacity and agrees not to take any action which would constitute or facilitate
the Unauthorized use or disclosure of Confidential Information.  The
Employee further agrees to take all reasonable measures to prevent the
Unauthorized use and disclosure of Confidential Information and to prevent
Unauthorized persons or entities from obtaining or using Confidential
Information.  The terms “Confidential Information” and “Unauthorized”
shall have the meanings set forth in Sections 4(e)(iii) and (iv) of this
Agreement respectively.

    

    (ii) Promptly
upon termination, for any reason, of the Employee’s employment with the Company,
the Employee agrees to deliver to the Company all property and materials within
the Employee’s possession or control which belong to the Company or which
contain Confidential Information.

    

    (iii) As used
in this Agreement, the term “Confidential Information” shall mean trade secrets,
confidential or proprietary information, and all other information, documents or
materials, owned, developed or possessed by the Company, its parents,
subsidiaries or affiliates, their respective predecessors and successors,
whether in tangible or intangible form, that is not generally known to the
public.  Confidential Information includes, but is not limited to, (a)
financial information, (b) products, (c) product and service costs, prices,
profits and sales, (d) new business ideas, (e) business strategies, (f) product
and service plans, (g) marketing plans and studies, (h) forecasts, (i) budgets,
(j) projections, (k) computer programs, (l) data bases and the documentation
(and information contained therein), (m) computer access codes and similar
information, (n) software ideas, (o) know-how, technologies, concepts and
designs, (p) research projects and all information connected with research and
development efforts, (q) records, (r) business relationships, methods and
recommendations, (s) existing or prospective client, customer, vendor and
supplier information (including, but not limited to, identities, needs,
transaction histories, volumes, characteristics, agreements, prices, identities
of individual contacts, and spending, preferences or habits), (t) training
manuals and similar materials used by the Company in conducting its business
operations, (u) skills, responsibilities, compensation and personnel files of
Company employees, directors and independent contractors, (v) competitive
analyses, (w) contracts with other parties, and (x) other confidential or
proprietary information that has not been made available to the general public
by the Company’s senior management.

    

    (iv) As used
in this Agreement, the term “Unauthorized” shall mean: (a) in contravention of
the Company’s policies or procedures; (b) otherwise inconsistent with the
Company’s measures to protect its interests in the Confidential Information; (c)
in contravention of any lawful instruction or directive, either written or oral,
of a Company employee empowered to issue such instruction or directive; (d) in
contravention of any duty existing under law or contract; or (e) to the
detriment of the Company.

    

    (v) In the
event that the Employee is requested by any governmental or judicial authority
to disclose any Confidential Information, the Employee shall give the Company
prompt notice of such request (including, by giving the Company a copy of such
request if it is in writing), such that the Company may seek a protective order
or other appropriate relief, and in any such proceeding the Employee shall
disclose only so much of the Confidential Information as is required to be
disclosed.

     

               f. Discoveries and
Works.  All discoveries and works made or conceived
by the
Employee during and in the course of Employee’s employment by the Company,
jointly or with others, that relate to the Company’s activities shall be owned
by the Company.  The terms “discoveries and works” include, by way of
example, inventions, computer programs (including documentation of such
programs), technical improvements, processes, drawings, and works of authorship,
including all educational and sales materials or other publications which relate
to Company’s current business.  The Employee shall promptly notify and
make full disclosure to, and execute and deliver any documents requested by, the
Company to evidence or better assure title to such discoveries and works by the
Company, assist the Company in obtaining or maintaining for itself at its own
expense United States and foreign patents, copyrights, trade secret protection
and other protection of any and all such discoveries and works, and promptly
execute, whether during Employee’s employment or thereafter, all applications or
other endorsements necessary or appropriate to maintain patents and other rights
for the Company and to protect its title thereto.  Any discoveries and
works which, within six (6) months after the termination of the Employee’s
employment hereunder, are made, disclosed, reduce to a tangible or written form
or description, or are reduced to practice by the Employee and which pertain to
work performed by the Employee while with, and in Employee’s capacity as an
Employee of the Company shall, as between the Employee and the Company presumed
to have been made during the Employee’s employment by the Company.

    

       g.Representations, Warranties
and Acknowledgements.

    

    (i) The
Employee acknowledges that (a) the Company considers Confidential
Information to be commercially and competitively valuable to the Company and
critical to its success; (b) Unauthorized use or disclosure of Confidential
Information would cause irreparable harm to the Company; and (c) by this
Agreement, the Company is taking reasonable steps to protect its legitimate
interests in its Confidential Information.

     

    (ii) The
Employee also acknowledges that businesses that are competitive with the Company
include, but are not limited to, any business in which the Company is actively
involved on the Employee’s termination date, including but not limited to any
business involving marketing, consulting to or contract sales, detailing and
marketing support or any other marketing services for pharmaceutical or any
other related health care or biotechnology companies, including competitive
e-health businesses, recruiting, training, sales operations, patient assistance,
medical education and/or analytics.

    

        (iii)The
Employee represents and warrants to the Company that Employee
is not a party to any agreement, or non-competition or other covenant or
restriction contained in any agreement, commitment, arrangement or understanding
(whether oral or written), that in any way conflicts with or limits the
Employee’s ability to commence or continue to render services to the Company or
that would otherwise limit the Employee’s ability to perform all
responsibilities in accordance with the terms and subject to the conditions of
the Employee’s employment.

         

            (iv)The
Employee acknowledges that certain accounts are national 

      and
international in scope and the location of the Company’s customers is not
dependent on the geographic location of the Employee or the
Company.

       

    

            
(v)The
Employee consents and agrees that, during the Employee’s employment
with Company and thereafter, the Company may review, audit, intercept, access
and disclose all communications created, received or sent over the electronic
mail and internet access system provided by Company with or without notice to
the Employee and that such review, audit, interception, access, or disclosure
may occur during or after working hours.  The Employee further
consents and agrees that the Company may, at any time, access and review the
contents of all computers, computer disks, other data storage equipment and
devices, files, desks, drawers, closets, cabinets and work stations which are
either on Company’s premises or which are owned or provided by
Company.

     

     

        h. Remedies. In the
event of breach or threatened breach by the Employee
of any provision of Section 4 hereof, the Company shall be entitled to obtain
(i) temporary, preliminary and permanent injunctive relief, in each case without
the posting of any bond or other security,  (ii) damages and an
equitable accounting of all earnings, profits and other benefits arising from
such breach, or threatened breach, (iii) recovery of all attorney’s fees and
costs incurred by the Company in obtaining such relief, (iv) repayment of any
severance benefits paid to the Employee pursuant to this Agreement or any
severance benefit agreement, plan or arrangement of the Company, and (v) any
other legal and equitable relief to which it may be entitled, including any and
all monetary damages which Company may incur as a result of said breach or
threatened breach.  Pending arbitration pursuant to Section 8 of the
Agreement, the Company shall be entitled to cease making any payments or
providing any benefits to the Employee and to obtain temporary and preliminary
injunctive relief as described in Section 4(h)(i) from a court of competent
jurisdiction.  The Company may pursue any remedy available, including
declaratory relief, concurrently or consecutively, in any order, and the pursuit
of one such remedy at any time will not be deemed an election of remedies or
waiver of the right to pursue any other remedy.

     

        i.Early Resolution
Conference.  This Agreement is understood to be clear
and
enforceable as written and is executed by both parties on that
basis.  However, should the Employee later challenge any provision as
unclear, unenforceable, or inapplicable to activity that the Employee intends to
engage in, the Employee will first notify Company in writing and meet with a
Company representative and a neutral mediator (if the Company elects to retain
one at its expense) to discuss resolution of any disputes between the
parties.  The Employee will provide this notification at least
fourteen (14) days before the Employee engages in any activity on behalf of a
competing business or engages in other activity that could foreseeably fall
within a questioned restriction.  The failure to comply with this
requirement shall waive the Employee’s right to challenge the reasonable scope,
clarity, applicability, or enforceability of the Agreement and its restrictions
at a later time.  All rights of both parties will be preserved if the
Early Resolution Conference requirement is complied with even if no agreement is
reached in the conference.

     

        5. Termination
of Employment.

               a. The
Employee is an employee at-will, and either the Employee or the
Company may terminate the employment relationship at any time for any reason
with or without Cause (as defined below).  The date upon which the
termination of the Employee’s employment becomes effective pursuant to this
Agreement shall be referred to herein as the “Termination Date.” The Termination
Date shall be the date upon which any of the following events shall
occur:

    

    (i) the death
of the Employee;

    

    (ii) the
Disability (as defined below) of the Employee;

    

    (iii) the
Company’s delivery of a written notice to the Employee of a
termination of the Employee’s employment for Cause (as defined
below);

    

    (iv) the
Company’s delivery of a written notice to the Employee of a termination of the
Employee’s employment Without Cause (as defined below); or

    

    (v) resignation
by the Employee.

    

        b. For
purposes of this Agreement, the “Disability” of the Employee shall mean the
Employee’s inability, because of mental or physical illness or incapacity,
whether total or partial, to perform one or more of the primary duties of the
Employee’s employment with or without reasonable accommodation, and which
continues for a length of time that exceeds any period of leave following which
the Employee may have a right to be restored to the same job or to an equivalent
job under federal, state or local law.

    

        c. For
purposes of this Agreement, the term “Cause”  shall mean the
Employee’s (i) conviction or entry of a plea of guilty or nolo contendere, with
respect to any felony; (ii) commission of any act of willful misconduct, gross
negligence, fraud or dishonesty; (iii) violation of any term of this Agreement
or any written policy of the Company; or (iv) inability to substantially meet
the performance objectives other than any failure raising from your capacity due
to physical or mental illness for the respective position.

    

        d. For
purposes of this Agreement, “Without Cause” shall mean for any
reason(s) whatsoever (other than the reasons described in Sections 5(a)(i),
5(a)(ii), 5(a)(iii), and 5(a)(v) hereof).

    

    6. Payments Upon Termination of
Employment.

    

    a. Death or
Disability.  If the Employee’s employment hereunder is
terminated due to the Employee’s death or Disability pursuant to Sections
5(a)(i) or (ii) hereof, the Company shall pay or provide to the Employee, the
Employee’s designated beneficiary or to the Employee’s estate (i) all base
salary pursuant to Section 3(a) hereof and any vacation pay pursuant to Section
3(f) hereof, in each case which has been earned but unpaid as of the Termination
Date; and (ii) any benefits to which the Employee may be entitled under any
employee benefits plan, policy or arrangement pursuant to Section 3(b) hereof
(including, but not limited to, life insurance and disability insurance) in
which Employee is a participant in accordance with the written terms of such
plan, policy or arrangement up to and including the Termination
Date.

    

    b. Termination for Cause or
Resignation.  If the Employee’s employment hereunder is
terminated by the Company for Cause pursuant to Section 5(a)(iii) or due to the
Employee’s resignation pursuant to Section 5(a)(v) (except if such resignation
is for Good Reason in connection with a Change in Control), the Company shall
pay or provide to the Employee (i) all base salary pursuant to Section 3(a)
hereof and any vacation pay pursuant to Section 3(d) hereof, in each case which
has been earned but unpaid as of the Termination Date; and (ii) any benefits to
which the Employee may be entitled under any employee benefits plan, policy or
arrangement pursuant to Section 3(f) hereof in which Employee is a participant
in accordance with the written terms of such plan, policy or arrangement up to
and including the Termination Date.

    

    c. Termination Without Cause
Apart from a Change in Control.  If prior to a Change in
Control or after six (6) months following a Change in Control the Company
terminates Employee’s employment with the Company Without Cause, subject to
Section 7, the Company shall award the Employee a lump sum severance payment
equal to twenty-six (26) weeks of the Employee’s base pay, less applicable
withholding, subject to the terms and conditions of this Agreement.

    

    d. Termination Without Cause or
Resignation for Good Reason Upon or within Six Months Following a Change in
Control.  If upon or within six (6) months following a Change
in Control (i) the Company (or any parent or subsidiary or successor of the
Company) terminates Employee’s employment with the Company other than for Cause,
death or disability, or (ii) the Employee resigns from such employment for Good
Reason, then, subject to Section 7, (A) Employee will be entitled to a lump sum
severance payment equal to fifty-two (52) weeks of the Employee’s base pay, less
applicable withholding, subject to the terms and conditions of this Agreement,
and (B)  all outstanding unvested stock options and restricted stock
awards  previously granted to Employee shall immediately become vested
and exercisable and salable upon such termination.

    

    

    (i) As
used herein, a “Change in Control” of the Company means a transaction or a
series of related transactions involving either (i) a sale, transfer or other
disposition of all or substantially all of the Company’s assets, (ii) the
consummation of a merger or consolidation of the Company or (iii) a sale or
exchange of capital stock of the Company, in any case as a result of which the
stockholders of the Company immediately prior to such transaction or series of
related transactions own, in the aggregate, less than a majority of the
outstanding voting capital stock or equity interests of the surviving, resulting
or transferee entity.

    

    (ii)As
used herein, “Good Reason” shall mean Employee’s resignation within thirty (30)
days following the expiration of any Company cure period (discussed below)
following the occurrence of one or more of the following, without Employee’s
consent: (i) a material diminution of Employee’s authority, duties or
responsibilities; provided, however, that a reduction in authority, duties, or
responsibilities solely by virtue of the Company being acquired and made part of
a larger entity (as, for example, when the Chief Executive Officer of the
Company remains as such following a change of control of the Company but is not
made the Chief Employee Officer of the acquiring corporation) will not
constitute “Good Reason”; (ii) material reduction in the Employee’s base salary;
(iii) the relocation of the offices of the Company more than one hundred (100)
miles from the Company’s Somerset, New Jersey office; or (iv) a material breach
of the Agreement by the Company.  Employee will not resign for Good
Reason without first providing the Company with written notice of the acts or
omissions constituting the grounds for “Good Reason” within ninety (90) days of
the initial existence of the grounds for “Good Reason” and a reasonable cure
period of not less than thirty (30) days following the date of such
notice.

    

    

    e. No Other
Payments.  Except as provided in this Section 6, the Employee
shall not be entitled to receive any other payments or benefits from the Company
due to the termination of the Employee’s employment, including but not limited
to, any employee benefits under any of the Company’s employee benefits plans or
arrangements (other than at the Employee’s expense under the Consolidated
Omnibus Budget Reconciliation Act of 1985 or pursuant to the written terms of
any pension benefit plan in which the Employee is a participant in which the
Company may have in effect from time to time) or any right to severance
benefits.

     

    7. Conditions to Receipt of
Severance; No Duty to Mitigate.

     

    a. Separation Agreement and
Release of Claims.  The receipt of any severance pursuant to
Section 6 will be subject to Employee signing and not revoking a separation
agreement and release of claims in a form reasonably satisfactory to the Company
(the “Release”) and provided that such Release becomes effective and irrevocable
no later than sixty (60) days following the termination date (such deadline, the
“Release Deadline”).  If the Release does not become effective and
irrevocable by the Release Deadline, Employee will forfeit any rights to
severance or benefits under this Agreement.  In no event will
severance payments or benefits be paid or provided until the Release becomes
effective and irrevocable.

     

    b. Section
409A.

     

    (i) Notwithstanding
anything to the contrary in this Agreement, no severance pay or benefits to be
paid or provided to Employee, if any, pursuant to this Agreement that, when
considered together with any other severance payments or separation benefits,
are considered deferred compensation under Code Section 409A, and the final
regulations and any guidance promulgated thereunder (“Section 409A”) (together,
the “Deferred Payments”) will be paid or otherwise provided until Employee has a
“separation from service” within the meaning of Section
409A.  Similarly, no severance payable to Employee, if any, pursuant
to this Agreement that otherwise would be exempt from Section 409A pursuant to
Treasury Regulation Section 1.409A-1(b)(9) will be payable until Employee has a
“separation from service” within the meaning of Section 409A.

     

    (ii)Any
severance payments or benefits under this Agreement that would be considered
Deferred Payments will be paid on, or, in the case of installments, will not
commence until, the sixtieth (60th) day following Employee’s separation from
service, or, if later, such time as required by Section
7(d)(iii).  Except as required by Section 7(d)(iii), any installment
payments that would have been made to Employee during the sixty (60) day period
immediately following Employee’s separation from service but for the preceding
sentence will be paid to Employee on the sixtieth (60th) day following
Employee’s separation from service and the remaining payments shall be made as
provided in this Agreement.

     

    (iii)Notwithstanding
anything to the contrary in this Agreement, if Employee is a “specified
employee” within the meaning of Section 409A at the time of Employee’s
termination (other than due to death), then the Deferred Payments that are
payable within the first six (6) months following Employee’s separation from
service will become payable on the first payroll date that occurs on or after
the date six (6) months and one (1) day following the date of Employee’s
separation from service.  All subsequent Deferred Payments, if any,
will be payable in accordance with the payment schedule applicable to each
payment or benefit.  Notwithstanding anything herein to the contrary,
if Employee dies following Employee’s separation from service, but prior to the
six (6) month anniversary of the separation from service, then any payments
delayed in accordance with this paragraph will be payable in a lump sum as soon
as administratively practicable after the date of Employee’s death and all other
Deferred Payments will be payable in accordance with the payment schedule
applicable to each payment or benefit.  Each payment and benefit
payable under this Agreement is intended to constitute a separate payment for
purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.

     

    (iv)Any
amount paid under this Agreement that satisfies the requirements of the
“short-term deferral” rule set forth in Section 1.409A-1(b)(4) of the Treasury
Regulations will not constitute Deferred Payments for purposes of clause (i)
above.

     

    (v)Any
amount paid under this Agreement that qualifies as a payment made as a result of
an involuntary separation from service pursuant to Section 1.409A-1(b)(9)(iii)
of the Treasury Regulations that does not exceed the Section 409A Limit (as
defined herein) will not constitute Deferred Payments for purposes of clause (i)
above.  For purposes of this Agreement, “Section 409A Limit” will mean
two (2) times the lesser of: (x) Employee’s annualized compensation based upon
the annual rate of pay paid to Employee during Employee’s taxable year preceding
Employee’s taxable year of Employee’s separation from service as determined
under Treasury Regulation Section 1.409A-1(b)(9)(iii)(A)(1) and any Internal
Revenue Service guidance issued with respect thereto; or (y) the maximum amount
that may be taken into account under a qualified plan pursuant to Section
401(a)(17) of the Internal Revenue Code for the year in which Employee’s
separation from service occurred.

     

    (vi)The
foregoing provisions are intended to comply with the requirements of Section
409A so that none of the severance payments and benefits to be provided
hereunder will be subject to the additional tax imposed under Section 409A, and
any ambiguities herein will be interpreted to so comply.  The Company
and Employee agree to work together in good faith to consider amendments to this
Agreement and to take such reasonable actions which are necessary, appropriate
or desirable to avoid imposition of any additional tax or income recognition
prior to actual payment to Employee under Section 409A.

    

    c. No Duty to
Mitigate.  Employee will not be required to mitigate the amount
of any payment contemplated by this Agreement, nor will any earnings that
Employee may receive from any other source reduce any such payment.

    

    8. Arbitration.

    

    a.Any
controversy or claim arising out of or relating to this Agreement, the
employment relationship between the Employee and the Company, or the termination
thereof, including the arbitrability of any controversy or claim, which cannot
be resolved amicably after a reasonable attempt to negotiate such a resolution
(including by exhaustion of all grievance or claims procedures made available by
the Company or any employee benefit plan of the Company) shall be submitted to
arbitration under the auspices of the American Arbitration Association in
accordance with its Commercial Dispute Resolution Procedures and Rules, as such
rules may be amended from time to time.  The arbitration will be held
at the American Arbitration Association’s Somerset, New Jersey office nearest to
the Company’s place of business where the Employee works or to which the
Employee reports.  The award of the arbitrator shall be final and
binding upon the parties, and judgment may be entered with respect to such award
in any court of competent jurisdiction.  Any arbitration under this
Agreement shall be governed by and subject to the confidentiality restrictions
set forth in Section 4(e) of this Agreement.  The Employee
acknowledges reading, prior to the signing of this agreement, the Commercial
Dispute Resolution Procedures and Rules of the American Arbitration Association,
which are available via the internet at
http://www.adr.org.  Notwithstanding the foregoing, any controversy or
claim arising out of or relating to any claim by the Company for temporary or
preliminary relief with respect to Section 4 of this Agreement need not be
resolved in arbitration and may be resolved in accordance with Section 4(h) of
this Agreement.

    

    b.The
Employee acknowledges that this agreement to submit to

    arbitration
includes all controversies or claims of any kind (e.g., whether in contract or
in tort, statutory or common law, legal or equitable) now existing or hereafter
arising under any federal, state, local or foreign law (except claims by the
Company for temporary or preliminary injunctive relief pursuant to Section 4 as
set forth above), including, but not limited to, the Age Discrimination in
Employment Act, Title VII of the Civil Rights Act of 1964, the Civil Rights Act
of 1866, the Family and Medical Leave Act, the Employee Retirement Income
Security Act, and the Americans With Disabilities Act, and all similar state
laws, and the Employee hereby waives all rights there under to have a judicial
tribunal resolve such claims.

    

    9.Deductions and
Withholding.  The Employee agrees that the Company shall
withhold from any and all compensation payable under this Agreement all federal,
state, local and/or other taxes which the Company determines are required to be
withheld under applicable statutes and/or regulations from time to time in
effect and all amounts required to be deducted in respect of the Employee’s
coverage by and participation in applicable Employee benefit plans, policies or
arrangements.

    

    10. Entire
Agreement.  This Agreement embodies the entire agreement of
the
parties with respect to the Employee’s employment and supersedes any other prior
oral or written agreements between the Employee and the Company and its
affiliates.  This Agreement may not be changed or terminated orally
but only by an agreement in writing signed by the parties hereto.

    

    11. Waiver.  The
waiver by the Company of a breach of any provision of this
Agreement by the Employee shall not operate or be construed as a waiver of any
subsequent breach by the Employee.  The waiver by the Employee of a
breach of any provision of this Agreement by the Company shall not operate or be
construed as a waiver of any subsequent breach by the Company.

    

    12.Governing
Law.  This Agreement shall be governed by, and construed in
accordance
with, the laws of the State of New Jersey, without regard to the choice of law
rules of any state or where the Employee is in fact required to
work.

    

    13.Jurisdiction.  Any
legal suit, action or proceeding against any party hereto arising out of or
relating to this Agreement that is not subject to arbitration pursuant to
Section 8 of this Agreement shall be instituted in a New Jersey federal court or
state court in the County of Somerset and each party hereto waives any objection
which it may now or hereafter have to the laying of venue of any such suit,
action or proceeding and each party hereto irrevocably submits to the
jurisdiction of any such court in any suit, action or proceeding.

    

    14.Assignability.  The
obligations of the Employee may not be delegated and,
except as expressly provided in Section 6(a) relating to the designation of
beneficiaries, the Employee may not, without the Company’s written consent
thereto, assign, transfer, convey, pledge, encumber, hypothecate or otherwise
dispose of this Agreement or any interest therein.  Any such attempted
delegation or disposition shall be null and void and without
effect.  The Company and the Employee agree that this Agreement and
all of the Company’s rights and obligations hereunder may be assigned or
transferred by the Company to and may be assumed by and become binding upon and
may inure to the benefit of any affiliate of or successor to the
Company.  The term “successor” shall mean (with respect to the Company
or any of its subsidiaries) any other corporation or other business entity
which, by merger, consolidation, purchase of the assets, or otherwise, acquires
all or a material part of the assets of the Company.  Any assignment
by the Company of its rights or obligations hereunder to any affiliate of or
successor to the Company shall not be a termination of employment for purposes
of this Agreement.

    

    15. Severability.  If
any provision of this Agreement as applied to either party or
to any circumstances shall be adjudged by a court of competent jurisdiction or
arbitrator to be void or unenforceable, the same shall in no way affect any
other provision of this Agreement or the validity or enforceability of this
Agreement.  If any court or arbitrator construes any of the provisions
of Section 4 hereof, or any part thereof, to be unreasonable because of the
duration of such provision or the geographic or other scope thereof, such court
or arbitrator may reduce the duration or restrict the geographic or other scope
of such provision and enforce such provision as so reduced or
restricted.

    

    16. Notices.  All
notices to the Employee hereunder shall be in writing and shall be
delivered personally, sent by overnight courier or sent by registered or
certified mail, return receipt requested, to:

    

    Mr. Nat
Krishnamurti

    c/o
inVentiv Health, Inc.

    500
Atrium Drive

    Somerset,
New Jersey 08873

    

    

    All
notices to the Company hereunder shall be in writing and shall be delivered
personally, sent by overnight courier or sent by registered or certified mail,
return receipt requested, to:

    inVentiv
Health, Inc.

    500
Atrium Drive

    Somerset,
New Jersey 08873

    Attention:  Chief
Resource Officer

    

    Either
party may change the address to which notices shall be sent by sending written
notice of such change of address to the other party.

    

    17. Section
Headings.  The section headings contained in this Agreement are
for
reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement.

     

    18. Counterparts.  This
Agreement may be executed in one or more counterparts,
each of which shall be deemed to be an original, but all of which taken together
shall constitute one and the same instrument.

    

    19. Voluntary
Agreement.  The Employee acknowledges that before entering
into this Agreement, the Employee has had the opportunity to consult with any
attorney or other advisor of Employee’s choice, and that this Section 19 of this
Agreement constitutes advice from the Company to do so if Employee
chooses.  The Employee further acknowledges that Employee entered into
this Agreement of Employee’s own free will, and that no promises or
representations have been made to Employee by any person to induce Employee to
enter into this Agreement other than the express terms set forth
herein.  The Employee further acknowledges that Employee has read this
Agreement and understands all of its terms, including the waiver of the right to
have all disputes with and claims against the Company decided in a judicial
forum set forth in Section 8.  The Employee may take up to seven (7)
days from today to consider, sign and return this Agreement.  In
addition, the Employee may revoke this Agreement after signing it, but only by
delivering a signed revocation notice to the Company within seven (7) days of
signing this Agreement.  Such a revocation shall automatically
terminate the Employee’s employment due to resignation pursuant to Section
5(a)(v).

    

     

    

     

    

    

    [Remainder
of Page Left Blank]

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    IN
WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the
date first above written.

    

    INVENTIV
HEALTH, INC.

    
 

    By: /s/ R. Blane Walter

    

    R. BLANE
WALTER

    CEO,
inVentiv Health Inc.

    

     

    EMPLOYEE

    

     

    By:
/s/ Nat Krishnamurti

     

    NAT
KRISHNAMURTI

    Chief Accounting Officer, inVentiv Health,
Inc.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}]]